A detailed history of Nisa Investment Advisors, LLC transactions in Rallybio Corp stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 25 shares of RLYB stock, worth $27. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 10 150.0%
Holding current value
$27
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

BUY
$1.34 - $2.98 $20 - $44
15 Added 150.0%
25 $0
Q1 2024

May 01, 2024

BUY
$1.25 - $2.4 $12 - $24
10 New
10 $0
Q3 2023

Nov 02, 2023

BUY
$3.37 - $6.16 $4,714 - $8,617
1,399 New
1,399 $4,000
Q4 2022

Feb 02, 2023

BUY
$4.67 - $14.86 $84 - $267
18 New
18 $0

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $35.7M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.